Gilead Sciences Inc
NASDAQ:GILD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Gilead Sciences Inc
NASDAQ:GILD
|
US |
|
Alliance Media Holdings Inc
OTC:ADTR
|
US |
|
Kuke Music Holding Ltd
NYSE:KUKE
|
CN |
|
T
|
Translational Development Acquisition Corp
NASDAQ:TDAC
|
US |
|
W
|
WoojinNTec Inc
KOSDAQ:457550
|
KR |
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
KR |
|
Dynacor Gold Mines Inc
TSX:DNG
|
CA |
|
Centrepoint Alliance Ltd
ASX:CAF
|
AU |
|
Bigben Interactive SA
PAR:BIG
|
FR |
|
Vection Technologies Ltd
ASX:VR1
|
AU |
|
Aegis Brands Inc
TSX:AEG
|
CA |
|
Union Gas Holdings Ltd
SGX:1F2
|
SG |
|
PDD Holdings Inc
NASDAQ:PDD
|
CN |
|
T
|
Telesat Corp
NASDAQ:TSAT
|
CA |
|
ODP Corp
NASDAQ:ODP
|
US |
|
Merko Ehitus AS
F:MKS
|
EE |
|
Monro Inc
NASDAQ:MNRO
|
US |
|
International Flavors & Fragrances Inc
NYSE:IFF
|
US |
|
Coca Cola HBC AG
LSE:CCH
|
CH |
|
R
|
RaonSecure Co Ltd
KOSDAQ:042510
|
KR |
|
M
|
MKB Nedsense NV
SWB:BFE
|
NL |
|
Universal Logistics Holdings Inc
NASDAQ:ULH
|
US |
Wall Street
Price Targets
GILD Price Targets Summary
Gilead Sciences Inc
According to Wall Street analysts, the average 1-year price target for
GILD
is 161.06 USD
with a low forecast of 119.18 USD and a high forecast of 189 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GILD's stock price target?
Price Target
161.06
USD
According to Wall Street analysts, the average 1-year price target for
GILD
is 161.06 USD
with a low forecast of 119.18 USD and a high forecast of 189 USD.
What is Gilead Sciences Inc's Revenue forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
Gilead Sciences Inc's revenue is
9%.
The projected
CAGR
for the next 3 years is
5%.
What is Gilead Sciences Inc's Operating Income forecast?
Projected CAGR
13%
For the last 14 years the
compound annual growth rate for
Gilead Sciences Inc's operating income is
8%.
The projected
CAGR
for the next 3 years is
13%.
What is Gilead Sciences Inc's Net Income forecast?
Projected CAGR
16%
For the last 14 years the
compound annual growth rate for
Gilead Sciences Inc's net income is
8%.
The projected
CAGR
for the next 3 years is
16%.
